Skip to main content
All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for ALKERMES, INC. · Biopharmaceutical company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $90,000.00 income · posted Jan 12, 2026

Official filing document

 Bills named in this filing 1
 Lobbying activity 1
Medicare/Medicaid

Medicare/Medicaid issues. Medicaid drug rebate program. Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. H.R.946 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem